Treatment of spasticity by botulinum toxin injections. A review;Traitement de la spasticite par injections de toxine botulique. Revue de la litterature

Neurochirurgie

Volumn 44, Issue 3, 1997, Pages 192-196

  Feve A ^a,b,c   Decq, Ph ^a   Filipetti, P ^a   Keravel Y ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b Centre de l'Arche   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

Botulinum toxin; Cerebral palsy; Gait; Spasticity

Indexed keywords

BOTULINUM TOXIN A; ANTIPARKINSON AGENT; BOTULINUM TOXIN;

ADULT; CEREBRAL PALSY; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GAIT; HUMAN; INJECTION SITE; INTRAMUSCULAR DRUG ADMINISTRATION; LEG MUSCLE; NEUROLOGIC DISEASE; PAIN; QUALITY OF LIFE; REVIEW; SPASTICITY; TREATMENT OUTCOME; ANIMAL; CONTROLLED CLINICAL TRIAL; INJECTION; INNERVATION; LIMB; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; EXTREMITIES; HUMANS; INJECTIONS; MUSCLE SPASTICITY; RANDOMIZED CONTROLLED TRIALS;

EID: 0031755147     PISSN: 00283770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. ACADEMY OF NEUROLOGY. Assessment : The clinical usefulness of botulinum toxin-A in treating neurologic disorders. Neurology 1990 ; 40 : 1332-1336.
2. BLASI J, CHAPMAN AER, LINK E, BINZ T, YAMASAKI S. Botulinum Neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993 : 365 : 160-163.
3. BRIN M, BLITZER A. Botulinum toxin, dangerous terminology errors. J R Soc Med, 1993 ; 86 : 493-494.
4. BURBAUD P, WlART L, DUBOS JL, GAUJARD E, DEBEILLE X, JOSEPH PA, MAZAUD JM, BIOULAC B, BARAT M, LAGUENY A. A randomized, double blind placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neural Neiirosurg Psychiatry 1996 ; 61 : 265-269.
5. COMELLA CL, BUCHMAN, AS, TANNER CM, BROWN-THO.MS NC, GOETZ CO. Botulinum toxin injection for spasmodic torticollis ; increased magnitude of benefit with electromyographic assistance. Neurology 1992 ; 42 : 878-882.
6. COSGROVE AP, CORRY IS, GRAHAM HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Devel Med Child Neural 1984 ; 36 : 386-396.
7. CALDERON-GONZALEZ R, CALDEROX-SEPULVEDA R, RINCONREYES M, GARCIA-RAMIREZ J, AND MINO-ARANGO E. Botulinum toxin A in management of cerebral palsy. Pedriatr Neural 1994 ; 19 : 284-288.
8. DAS TK, PARK DM. Effect of treatment of botulinum toxin on spasticity. Postgrad Med J 1989 ; 65 : 209-210.
9. DAS TK, PARK DM. Botulinum toxin in treating spasticity. BJCP 1989 ; 43 : 401-403.
10. DUNNE JW, HEYE N, DüNNE SL. Treatment of chronic limb spasticity with botulinum toxin A. J Neural Neiirosurg Psychiatry 1995 ; 58: 232-235.
11. GOOCH JL, SANDELL TV. Botulinum toxin for spasticity and athetosis in children with cerebral palsy. Arch Phys Med Rehabil 1996 ; 77 : 508-511.
12. GRAZKO MA, POLO KB, JABBARI B. Botulinum toxin A for spasticity, muscles spasms, and rigidity. Neurology 1995; 45: 712-717.
13. HAMBLETON P. Clostridium botulinum toxins ; a general review of involvement in disease, structure, mode of action, and preparation for clinical use. J Neural 1992 ; 259: 16-20.
14. HESSE S, FRIEDRICH H, DOMASCH CH, MAURITZ KH. Botulinum toxin therapy for upper limb flexor spasticity ; preliminary results. J Rehab Sei 1992 ; 5 : 98-101.
15. HESSE S, LüCKE D, MALEZIC M, BERTELT C, FRIEDRICH H, GREGORIC M, MAURITZ KH. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neural Neiirosurg Psychiatry 1994 ; 57 : 1321-1324.
16. HESSE S, JAIINKE MT, LUECKE D, MAURITZ KH. Short term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 1995 ; 207 : 37-40.
17. HESSE S, KRAJNIK J, LUECKE D, JAHNKE MT, GREGORIC M, MAURITZ KH. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 1996; 27: 455-460.
18. HUGHES AJ. Botulinum toxin in clinical practice. Drugs 1994 ; 48 : 888-893.
19. HUGHES R, WALKER BC. Influence of nerve ending activity and of drugd on the rate of paralysis of rat diaphragm preparations by Closttridium botulinum toxin type A. J Physiol 1962 ; 160 : 221-233.
20. JANKOVIC J, BRIN MF. The therapeutic uses of botulinum toxins. N Engl J Med 1991 ; 324 : 1186-1194.
21. JANKOVIC J, SCHWARTZ K. Clinical correlates of response to botulinum toxin injections. Arch Neural 1991 ; 48 : 1253-1256.
22. JANKOVIC J, SCHWARTZ K. Response in immunoresistance to botulinum toxin injections. Neurology 1995 ; 45 : 1743-1746.
23. JOZEFCZYK PB. Approach to the management of focal spasticity. Am Acad Neural 1997 ; Vol. 3.
24. KöLTGEN D, CEBALLOS-BAUMANN AO, FRANKE C. Botulinum toxin converts muscle acetylcholine receptors from adults to embryonic type. Muscle Nerve 1994 ; 17 : 779784.
25. National Institutes of Health Consensus Development Conference Statement, November 12-14, 1990. Clinical use of botulinum toxin. Arch Neural 1991 ; 48 : 12941298.
26. PIERSON SH, KATZ DI, TARSY D. Botulinum toxin A in the treatment of spasticity : Functional implications and patient selection. Arch Phys Med Rehabil 1996; 77: 717-721.
27. PULLMAN SL, GREENE P, FAIIN S, PEDERSEN SF. Approach to the treatment of limb disorders with botulinum toxin A. Arch Neural 1996 ; 53 : 617-624.
28. REITER F, DANNT M, CERAVOLO MG, PROVLVCIALI L. Disability changes after treatment of upper limb spasticity with botulinum toxin. J Neural Rehab 1996 ; 10 : 47-52.
29. SCHIAVO G, ROSSETTE O, CATSICAS S, POLVERINO DE LAURETO P. Identification of the nerve terminal targets of botulinum serotypes A, D and E. J Biol Client 1993 ; 268: 23784-23787.
30. SCOTT AB, SUZUKI D. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. A/or Disord 1988 ; 3 : 333-335.
31. SIMPSON DM, ALEXANDER DN, O'BRIEN CF, TAGLIATI M, ASWAD AS, LEON JM, GIBSON J, MORDAUNT JM, MONAGIIAN EP. Botulinum toxin type A in the treatment of upper extremity spasticity ; a randomized doubleblind placebo-controlled trial. Neurology 1996 ; 46 : 1306-1310.
32. SNOW BJ, Tsui JK, BHATT BH, VARELAS M, HASIIIMOTO SA, CALNE DB. Treatment of spasticity with botulinum toxin ; a double blind study. Ann Neural 1990 ; 28 : 512-515.
33. YABLON SA, BENJAMIN TA, IVANIIOE CB, BOAKE C. Botulinum toxin in severe upper limb spasticity among patients with traumatic brain injury : an open labeled trial. Neurology 1996 ; 4 : 1306-1310.